http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112007069-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_925c1f148a6e83352cf37ac1d2152b18 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-481 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K131-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-481 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2019-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a50d94537f0ca48119bd49a25241577c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87b1b9d3e60d3aecc300b2961244a081 |
| publicationDate | 2020-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112007069-A |
| titleOfInvention | Application of total flavonoids of Fructus Shayuanzi in the preparation of anti-inflammatory drugs |
| abstract | The invention belongs to the field of traditional Chinese medicine pharmacy, and relates to the application of the total flavonoids from the active part extracted from the Chinese herbal medicine S. The experimental results show that the total flavonoids of the present invention can inhibit the aggregation of macrophages in the inflammatory injury area of the zebrafish inflammation model, and can significantly inhibit the expression of iNOS gene; , IL-1, IL6, TNF-a gene and NF-kB, I-kB protein have obvious inhibitory effect. The total flavonoids of A. chinensis in the present invention can be used as raw materials to further prepare pharmaceutical preparations for anti-inflammatory and angiogenesis deficiency-related diseases, which are used for acute and chronic inflammatory injury, overexpression of inflammatory factors in cardiovascular diseases and other diseases related to excessive inflammatory reactions. prevention and treatment. |
| priorityDate | 2019-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 138.